India's pharmaceutical manufacturing sector supplies over 20% of the world's generic medicines and over 50% of global vaccines. With stringent regulatory oversight from the US FDA, UK MHRA, WHO, and CDSCO (Revised Schedule M), document control systems must deliver uncompromising data integrity, sub-second response times, and robust physical print governance.
Novaqis DMS has established itself as India's premier enterprise GxP document management platform. Featuring web-native collaborative authoring, copy-numbered pantograph printing, cryptographic dual-signature destructions, and instant interlocks with LMS and QMS, Novaqis protects manufacturing facilities from audit observations while accelerating document lifecycle velocity.